ARCHIVES

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

HHS Carcinogen Guidelines For Labs Could Apply To Other

May 30, 1980

ACCC Recommends Cancer Act Changes

August 27, 1976

New ACS Grants to Fund ‘Critical, Urgent’ Research

April 15, 1977

Also Anna Barker gets new, longer title at NCI; Mark Clanton named deputy director for care, delivery.

February 13, 2004

In Brief: New York Legislature Votes $240 Mil. Bond Issue For Roswell Park Construction; Kripke Honored

April 25, 1992

FDA Approves Silicone Gel Breast Implants, Requires 10 Years Of Patient Follow-Up

November 24, 2006